Leadership

Dr. Cutler was founder and director of California Clinical Trials from 1987–1999, which was one of the largest Phase I–III clinical pharmacology and investigational sites in the United States. This was expanded into a global CRO, also named Worldwide Clinical Trials, which he successfully merged into a subsidiary of UnitedHealth Group Inc.

Dr. Cutler is a board-certified psychiatrist and board-qualified in both neurology and clinical pharmacology. He currently serves as the Adjunct Professor of Medicine, Department of Medicine/Cardiology at the University of Colorado School of Medicine. He worked at the National Institutes of Health (NIH) for over nine years and served as both the section chief for the Laboratory of Neuroscience and as deputy clinical director of the National Institute on Aging (NIA). He also served as an expert to the Food and Drug Administration Division of Neuropharmacological Agents from 1981-1983. He was previously president of the American Foundation for Clinical Pharmacology and served on a special emphasis panel review committee for the National Institute on Aging for the NIH.

Dr. Cutler has been instrumental in the design and clinical development of over 500 compounds in numerous therapeutic areas, with expertise in central nervous system disorders. He developed the revolutionary “dynabridge” and “bridging” study methodologies, which made feasible the study of the dynamic activity of a compound in the brain and facilitated the rapid and effective development of several subsequent compounds.

Dr. Cutler has given several hundred international and national presentations in the fields of aging, migraine, clinical pharmacology, and drug development. He has authored over 280 publications, including 9 books on the topics of clinical pharmacology, aging, Alzheimer’s disease, schizophrenia, anxiety disorders and diabetes.

He has clinical pharmacology and clinical trial expertise in a wide range of indications including Alzheimer’s disease, schizophrenia, depression, anxiety disorders, migraine, and cardiovascular disorders.

Dr. Sramek earned a Pharm.D. from the University of Southern California and holds undergraduate and graduate degrees in biology and psychology.

Before Concierge Clinical Trials, Samuel served as Vice President of Finance for Worldwide Clinical Trials, a global clinical research organization. Prior to that, he was Vice President of Finance for Alamo Pharmaceuticals, a biotechnology company, and held a senior leadership position at California Clinical Trials, a clinical trial site located in Beverly Hills.

Samuel earned his Bachelor of Science in Accounting at Oral Roberts University in Tulsa Oklahoma. He secured his public accounting experience at the big four accounting firm Deloitte & Touche.

Samuel is a licensed CPA (inactive) in California. He resides in Los Angeles with his wife and their daughter and two sons.

Throughout his tenure, Modesto has demonstrated a keen ability to lead cross-functional teams, manage complex operations, and foster a collaborative environment. His leadership is characterized by a strategic vision, operational efficiency, and dedication to advancing the field of health research. His support in clinical operations has brought comfort to sponsors, patients and staff alike in this industry.

Modesto began his career as an EMT. He earned a bachelor’s degree in organizational leadership, equipping him with essential skills in management and strategy. Today, Modesto is deeply involved in clinical research, where he combines his hands-on medical experience with his research expertise to contribute to the advancement of healthcare.

Prior to his current roles, Anthony worked as an IT Support Technician at Worldwide Clinical Trials, where he provided crucial support to internal and external organizations, managed IT assets, and supported the Founder and CEO.

Anthony holds a Bachelor of Arts in Criminal Justice from Long Island University and gained valuable IT experience working for large school districts in Connecticut.